Avendus, SBI Life pick up over 2.5% secondaries in Aragen for Rs 300 crore
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Avendus Future Leaders Fund III and SBI Life Insurance have jointly invested Rs 300 crore in Aragen Life Sciences, a Hyderabad-based CRDMO. The investment involves acquiring a stake from the GVK Group's Reddy family. This move allows investors to capitalize on the increasing trend of global pharmaceutical companies outsourcing R&D and manufacturing to India. What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
